S&P 500   3,841.42 (-1.52%)
DOW   30,857.74 (-1.27%)
QQQ   281.69 (-2.72%)
AAPL   133.85 (-2.55%)
MSFT   246.78 (-2.51%)
FB   189.83 (-0.76%)
GOOGL   2,124.24 (-3.78%)
AMZN   2,107.67 (-1.80%)
TSLA   639.00 (-9.93%)
NVDA   159.90 (-6.62%)
BABA   85.47 (-2.53%)
NIO   15.93 (-4.38%)
AMD   89.59 (-7.32%)
CGC   5.38 (-8.35%)
MU   66.63 (-3.99%)
T   20.21 (+0.10%)
GE   74.13 (-2.13%)
F   12.27 (-4.51%)
DIS   100.63 (-2.43%)
AMC   11.56 (-11.62%)
PFE   51.91 (+2.49%)
PYPL   78.08 (-3.94%)
NFLX   181.34 (-1.17%)
S&P 500   3,841.42 (-1.52%)
DOW   30,857.74 (-1.27%)
QQQ   281.69 (-2.72%)
AAPL   133.85 (-2.55%)
MSFT   246.78 (-2.51%)
FB   189.83 (-0.76%)
GOOGL   2,124.24 (-3.78%)
AMZN   2,107.67 (-1.80%)
TSLA   639.00 (-9.93%)
NVDA   159.90 (-6.62%)
BABA   85.47 (-2.53%)
NIO   15.93 (-4.38%)
AMD   89.59 (-7.32%)
CGC   5.38 (-8.35%)
MU   66.63 (-3.99%)
T   20.21 (+0.10%)
GE   74.13 (-2.13%)
F   12.27 (-4.51%)
DIS   100.63 (-2.43%)
AMC   11.56 (-11.62%)
PFE   51.91 (+2.49%)
PYPL   78.08 (-3.94%)
NFLX   181.34 (-1.17%)
S&P 500   3,841.42 (-1.52%)
DOW   30,857.74 (-1.27%)
QQQ   281.69 (-2.72%)
AAPL   133.85 (-2.55%)
MSFT   246.78 (-2.51%)
FB   189.83 (-0.76%)
GOOGL   2,124.24 (-3.78%)
AMZN   2,107.67 (-1.80%)
TSLA   639.00 (-9.93%)
NVDA   159.90 (-6.62%)
BABA   85.47 (-2.53%)
NIO   15.93 (-4.38%)
AMD   89.59 (-7.32%)
CGC   5.38 (-8.35%)
MU   66.63 (-3.99%)
T   20.21 (+0.10%)
GE   74.13 (-2.13%)
F   12.27 (-4.51%)
DIS   100.63 (-2.43%)
AMC   11.56 (-11.62%)
PFE   51.91 (+2.49%)
PYPL   78.08 (-3.94%)
NFLX   181.34 (-1.17%)
S&P 500   3,841.42 (-1.52%)
DOW   30,857.74 (-1.27%)
QQQ   281.69 (-2.72%)
AAPL   133.85 (-2.55%)
MSFT   246.78 (-2.51%)
FB   189.83 (-0.76%)
GOOGL   2,124.24 (-3.78%)
AMZN   2,107.67 (-1.80%)
TSLA   639.00 (-9.93%)
NVDA   159.90 (-6.62%)
BABA   85.47 (-2.53%)
NIO   15.93 (-4.38%)
AMD   89.59 (-7.32%)
CGC   5.38 (-8.35%)
MU   66.63 (-3.99%)
T   20.21 (+0.10%)
GE   74.13 (-2.13%)
F   12.27 (-4.51%)
DIS   100.63 (-2.43%)
AMC   11.56 (-11.62%)
PFE   51.91 (+2.49%)
PYPL   78.08 (-3.94%)
NFLX   181.34 (-1.17%)

Cantor Fitzgerald Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cantor Fitzgerald. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cantor Fitzgerald.

All countries
MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
Export to Excel
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
CWEB
Charlotte's Web
5/18/2022Reiterated byCantor FitzgeraldHold C$0.70N/A
VLTA
Volta
5/18/2022Target Lowered byCantor FitzgeraldAnalyst A. Sheppard$8.00 -> $6.00High
AGTC
Applied Genetic Technologies
5/17/2022Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightLow
SPRO
Spero Therapeutics
5/17/2022Target Lowered byCantor Fitzgerald$27.00 -> $5.00High
AYTU
Aytu BioPharma
5/17/2022Target Lowered byCantor Fitzgerald$11.00 -> $5.00High
ELDN
Eledon Pharmaceuticals
5/13/2022Initiated byCantor FitzgeraldAnalyst P. StavropoulosOverweight$25.00 -> $15.00Low
FBIO
Fortress Biotech
5/13/2022Reiterated byCantor FitzgeraldAnalyst Jennifer KimBuy $6.00High
PSTX
Poseida Therapeutics
5/13/2022Initiated byCantor FitzgeraldAnalyst Jennifer KimBuy $24.00Medium
VERU
Veru
5/13/2022Reiterated byCantor FitzgeraldAnalyst B. FolkesOverweightHigh
SMRT
SmartRent
5/12/2022Upgraded byCantor FitzgeraldAnalyst B. SherlundNeutral -> OverweightLow
ACB
Aurora Cannabis
5/13/2022Target Lowered byCantor FitzgeraldC$7.60 -> C$3.90High
ASND
Ascendis Pharma A/S
5/12/2022Target Lowered byCantor FitzgeraldAnalyst L. Watsek$230.00 -> $180.00High
ETNB
89bio
5/12/2022Target Lowered byCantor Fitzgerald$41.00 -> $27.00High
TGTX
TG Therapeutics
5/9/2022Reiterated byCantor FitzgeraldAnalyst P. AgrawalOverweightHigh
TCRT
Alaunos Therapeutics
5/9/2022Reiterated byCantor FitzgeraldAnalyst P. AgrawalOverweightLow
RGLS
Regulus Therapeutics
5/9/2022Reiterated byCantor FitzgeraldAnalyst P. StavropoulosOverweightLow
PSTX
Poseida Therapeutics
5/9/2022Reiterated byCantor FitzgeraldAnalyst J. KimOverweightLow
PRQR
ProQR Therapeutics
5/9/2022Reiterated byCantor FitzgeraldAnalyst J. KimOverweightLow
IMNM
Immunome
5/9/2022Reiterated byCantor FitzgeraldAnalyst P. StavropoulosOverweightHigh
HARP
Harpoon Therapeutics
5/9/2022Reiterated byCantor FitzgeraldAnalyst J. KimOverweightMedium
GOSS
Gossamer Bio
5/9/2022Reiterated byCantor FitzgeraldAnalyst O. BrayerOverweightHigh
FMTX
Forma Therapeutics
5/9/2022Reiterated byCantor FitzgeraldAnalyst P. AgrawalOverweightHigh
EQ
Equillium
5/9/2022Reiterated byCantor FitzgeraldAnalyst P. AgrawalOverweightMedium
BHVN
Biohaven Pharmaceutical
5/11/2022Downgraded byCantor FitzgeraldAnalyst C. DuncanOverweight -> NeutralLow
BCRX
BioCryst Pharmaceuticals
5/9/2022Reiterated byCantor FitzgeraldAnalyst P. StavropoulosOverweightLow
ARCT
Arcturus Therapeutics
5/9/2022Reiterated byCantor FitzgeraldAnalyst P. StavropoulosOverweightHigh
ALLK
Allakos
5/9/2022Reiterated byCantor FitzgeraldAnalyst J. KimOverweightHigh
GRAY
Graybug Vision
5/11/2022Target Lowered byCantor FitzgeraldAnalyst Jennifer Kim$4.00 -> $2.50Medium
INO
Inovio Pharmaceuticals
5/11/2022Target Lowered byCantor Fitzgerald$6.00 -> $3.00High
SFT
Shift Technologies
5/11/2022Target Lowered byCantor Fitzgerald$8.00 -> $4.00High
HRTX
Heron Therapeutics
5/10/2022Target Lowered byCantor FitzgeraldAnalyst B. Folkes$20.00 -> $12.00High
ARDX
Ardelyx
5/6/2022Downgraded byCantor FitzgeraldAnalyst L. ChenOverweight -> Neutral$7.00 -> $1.00Medium
ETTX
Entasis Therapeutics
5/6/2022Downgraded byCantor FitzgeraldAnalyst L. ChenOverweight -> NeutralMedium
TXMD
TherapeuticsMD
5/6/2022Downgraded byCantor FitzgeraldAnalyst L. ChenOverweight -> NeutralHigh
PACB
Pacific Biosciences of California
5/5/2022Target Lowered byCantor FitzgeraldAnalyst R. Osborn$23.00 -> $19.00High
SMTI
Sanara MedTech
5/2/2022Reiterated byCantor FitzgeraldAnalyst R. OsbornOverweightLow
SPT
Sprout Social
5/4/2022Target Lowered byCantor Fitzgerald$99.00 -> $80.00High
AUPH
Aurinia Pharmaceuticals
4/28/2022Reiterated byCantor FitzgeraldAnalyst O. BrayerOverweightHigh
EBS
Emergent BioSolutions
4/29/2022Downgraded byCantor FitzgeraldAnalyst B. FolkesOverweight -> NeutralLow
ROIV
Roivant Sciences
4/29/2022Initiated byCantor FitzgeraldOverweight $15.00High
GBT
Global Blood Therapeutics
4/28/2022Initiated byCantor FitzgeraldAnalyst Li WatsekBuy $75.00High
SIOX
Sio Gene Therapies
4/28/2022Downgraded byCantor FitzgeraldAnalyst K. KluskaOverweight -> Neutral $0.80High
EVGO
EVgo
4/28/2022Initiated byCantor FitzgeraldAnalyst A. SheppardOverweight $14.00Medium
SPNE
SeaSpine
4/22/2022Target Lowered byCantor FitzgeraldAnalyst R. OsbornOverweight$27.00 -> $21.00Medium
MRNS
Marinus Pharmaceuticals
4/20/2022Target Raised byCantor FitzgeraldAnalyst C. Duncan$25.00 -> $28.00High
PRQR
ProQR Therapeutics
4/19/2022Target Lowered byCantor FitzgeraldAnalyst B. Cheng$6.00 -> $3.50Low
SPNE
SeaSpine
4/12/2022Reiterated byCantor FitzgeraldAnalyst R. OsbornOverweightN/A
DRTS
Alpha Tau Medical
4/14/2022Initiated byCantor FitzgeraldAnalyst K. KluskaOverweight $20.00High
HRMY
Harmony Biosciences
4/14/2022Initiated byCantor FitzgeraldAnalyst C. DuncanOverweight $63.00Low
BCYC
Bicycle Therapeutics
4/7/2022Initiated byCantor FitzgeraldAnalyst L. WatsekOverweight$100.00 -> $80.00High
APTX
Aptinyx
4/8/2022Target Lowered byCantor FitzgeraldAnalyst C. DuncanOverweight$11.00 -> $5.00High
PAGS
PagSeguro Digital
4/8/2022Initiated byCantor FitzgeraldOverweight $25.00Low
STNE
StoneCo
4/8/2022Initiated byCantor FitzgeraldAnalyst J. SieglerOverweight $15.00Medium
SIBN
SI-BONE
4/7/2022Initiated byCantor FitzgeraldOverweight $34.00Medium
TLRY
Tilray
4/7/2022Target Raised byCantor FitzgeraldNeutral$6.90 -> $8.40High
ISPO
Inspirato
4/7/2022Initiated byCantor FitzgeraldAnalyst B. SherlundNeutral $9.00Low
JOBY
Joby Aviation
4/5/2022Initiated byCantor FitzgeraldAnalyst A. SheppardOverweight $10.00High
CRIS
Curis
4/5/2022Target Lowered byCantor FitzgeraldAnalyst L. Watsek$12.00 -> $4.00High
XNCR
Xencor
4/1/2022Reiterated byCantor FitzgeraldAnalyst P. StavropoulosOverweightN/A
VSTM
Verastem
4/1/2022Reiterated byCantor FitzgeraldAnalyst P. StavropoulosOverweightN/A
THRX
Theseus Pharmaceuticals
4/1/2022Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightN/A
TGTX
TG Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst B. ChengOverweightN/A
TCRT
Alaunos Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst B. ChengOverweightN/A
APS
Aptose Biosciences
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
STOK
Stoke Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst C. DuncanOverweightN/A
RCUS
Arcus Biosciences
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
PTCT
PTC Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweight$64.00 -> $63.00N/A
PRVB
Provention Bio
4/1/2022Reiterated byCantor FitzgeraldAnalyst P. AgrawalOverweightN/A
NEXI
NexImmune
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
MRNS
Marinus Pharmaceuticals
4/1/2022Reiterated byCantor FitzgeraldAnalyst C. DuncanOverweightN/A
LBPH
Longboard Pharmaceuticals
4/1/2022Reiterated byCantor FitzgeraldAnalyst C. DuncanOverweightN/A
GBT
Global Blood Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
FMTX
Forma Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst B. ChengOverweightN/A
FATE
Fate Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
CRIS
Curis
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
CBAY
CymaBay Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightN/A
BCYC
Bicycle Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweight$100.00 -> $80.00N/A
AUPH
Aurinia Pharmaceuticals
4/1/2022Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightN/A
ASND
Ascendis Pharma A/S
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
ARWR
Arrowhead Pharmaceuticals
4/1/2022Reiterated byCantor FitzgeraldAnalyst P. AgrawalOverweightN/A
ARVN
Arvinas
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
APTO
Aptose Biosciences
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
ALXO
ALX Oncology
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
ALGS
Aligos Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst L. WatsekOverweightN/A
SPT
Sprout Social
4/5/2022Initiated byCantor FitzgeraldOverweight $99.00N/A
SPPI
Spectrum Pharmaceuticals
4/1/2022Reiterated byCantor FitzgeraldAnalyst A. YoungNeutralHigh
RAPT
RAPT Therapeutics
4/1/2022Reiterated byCantor FitzgeraldAnalyst A. YoungOverweightHigh
AKBA
Akebia Therapeutics
4/1/2022Downgraded byCantor FitzgeraldAnalyst P. StavropoulosOverweight -> NeutralLow
CRNX
Crinetics Pharmaceuticals
3/31/2022Reiterated byCantor FitzgeraldAnalyst C. DuncanOverweightHigh
MIGI
Mawson Infrastructure Group
3/30/2022Initiated byCantor FitzgeraldAnalyst M. ColonneseOverweight $12.00Low
NKTX
Nkarta
3/29/2022Reiterated byCantor FitzgeraldAnalyst A. YoungOverweightHigh
ELDN
Eledon Pharmaceuticals
3/29/2022Reiterated byCantor FitzgeraldAnalyst A. YoungOverweightLow
PWSC
PowerSchool
3/29/2022Initiated byCantor FitzgeraldOverweight $20.00High
TWOU
2U
3/29/2022Initiated byCantor FitzgeraldNeutral $12.00High
NRDY
Nerdy
3/29/2022Initiated byCantor FitzgeraldOverweight $7.00High
UDMY
Udemy
3/29/2022Initiated byCantor FitzgeraldOverweight $22.00Low
COUR
Coursera
3/29/2022Initiated byCantor FitzgeraldOverweight $30.00High
GRAY
Graybug Vision
3/25/2022Reiterated byCantor FitzgeraldAnalyst Jennifer KimBuy $4.00Low
XELA
Exela Technologies
3/24/2022Target Lowered byCantor FitzgeraldOverweight$4.00 -> $2.00Medium
VYNE
VYNE Therapeutics
3/18/2022Reiterated byCantor FitzgeraldAnalyst L. ChenOverweightLow
AYRWF
Ayr Wellness
3/18/2022Target Lowered byCantor FitzgeraldNeutral$17.50 -> $13.30Medium
HITI
High Tide
3/18/2022Target Lowered byCantor FitzgeraldNeutral$7.25 -> $7.00High
GRAY
Graybug Vision
3/17/2022Target Lowered byCantor FitzgeraldOverweight$6.00 -> $4.00High
TRSSF
TerrAscend
3/17/2022Target Raised byCantor FitzgeraldOverweight$7.65 -> $7.90High
OPNT
Opiant Pharmaceuticals
3/16/2022Reiterated byCantor FitzgeraldAnalyst B. FolkesOverweightHigh
NEXI
NexImmune
3/15/2022Reiterated byCantor FitzgeraldAnalyst A. YoungOverweightHigh
NHWK
NightHawk Biosciences
3/15/2022Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightHigh
ANIP
ANI Pharmaceuticals
3/16/2022Reiterated byCantor FitzgeraldAnalyst B. FolkesNeutralMedium
ALXO
ALX Oncology
3/14/2022Target Lowered byCantor Fitzgerald$103.00 -> $60.00High
ACRX
AcelRx Pharmaceuticals
3/11/2022Reiterated byCantor FitzgeraldAnalyst B. FolkesOverweightHigh
FMTX
Forma Therapeutics
3/11/2022Target Lowered byCantor FitzgeraldAnalyst A. Young$68.00 -> $46.00High
ML
MoneyLion
3/11/2022Target Lowered byCantor FitzgeraldAnalyst J. Siegler$8.00 -> $5.00High
ACAD
ACADIA Pharmaceuticals
3/10/2022Target Raised byCantor FitzgeraldOverweight$32.00 -> $37.00High
IREN
Iris Energy
3/9/2022Target Lowered byCantor FitzgeraldAnalyst M. Colonnese$25.00 -> $22.00High
MVIS
MicroVision
3/7/2022Initiated byCantor FitzgeraldAnalyst A. SheppardNeutral $5.00High
VFF
Village Farms International
3/7/2022Target Lowered byCantor FitzgeraldOverweight$12.75 -> $9.30High
EYPT
EyePoint Pharmaceuticals
3/4/2022Reiterated byCantor FitzgeraldAnalyst J. KimOverweightHigh
EOLS
Evolus
3/4/2022Reiterated byCantor FitzgeraldAnalyst L. ChenOverweight $20.00High
TLRY
Tilray Brands
3/4/2022Reiterated byCantor FitzgeraldNeutral C$9.00N/A
HEXO
HEXO
3/4/2022Target Lowered byCantor FitzgeraldNeutral$1.20 -> $0.90High
JAZZ
Jazz Pharmaceuticals
3/2/2022Reiterated byCantor FitzgeraldAnalyst B. FolkesOverweightLow
AMRN
Amarin
3/2/2022Reiterated byCantor FitzgeraldAnalyst L. ChenOverweightMedium
CRIS
Curis
3/2/2022Target Lowered byCantor Fitzgerald$24.00 -> $12.00High
CLDX
Celldex Therapeutics
3/1/2022Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightLow
ARDX
Ardelyx
3/1/2022Reiterated byCantor FitzgeraldAnalyst L. ChenOverweightHigh
HRTX
Heron Therapeutics
3/1/2022Target Lowered byCantor FitzgeraldAnalyst B. FolkesOverweight$26.00 -> $20.00High
ARCT
Arcturus Therapeutics
3/1/2022Target Lowered byCantor Fitzgerald$93.00 -> $86.00Low
HEPA
Hepion Pharmaceuticals
2/28/2022Initiated byCantor FitzgeraldAnalyst K. KluskaOverweight $3.50High
JSPR
Jasper Therapeutics
2/28/2022Initiated byCantor FitzgeraldAnalyst P. StavropoulosOverweight $10.00Low
ACRS
Aclaris Therapeutics
2/25/2022Reiterated byCantor FitzgeraldAnalyst L. ChenOverweightHigh
GDYN
Grid Dynamics
2/25/2022Target Lowered byCantor Fitzgerald$40.00 -> $25.00High
LTCH
Latch
2/25/2022Downgraded byCantor FitzgeraldAnalyst B. SherlundOverweight -> Neutral$16.00 -> $5.00High
GTBIF
Green Thumb Industries
2/25/2022Target Lowered byCantor FitzgeraldOverweight$54.00 -> $41.00High
MAPS
WM Technology
2/24/2022Target Raised byCantor FitzgeraldOverweight$6.25 -> $7.65High
VNRX
VolitionRx
2/18/2022Reiterated byCantor FitzgeraldAnalyst R. OsbornOverweightN/A
ARQT
Arcutis Biotherapeutics
2/23/2022Reiterated byCantor FitzgeraldAnalyst L. ChenOverweightHigh
AFMD
Affimed
2/23/2022Initiated byCantor FitzgeraldAnalyst L. WatsekOverweight $12.00High
HITI
High Tide
2/22/2022Target Lowered byCantor FitzgeraldNeutral$7.75 -> $7.25High
PSTX
Poseida Therapeutics
2/18/2022Initiated byCantor FitzgeraldAnalyst Brian ChengBuy $24.00High
CGC
Canopy Growth
2/18/2022Target Raised byCantor FitzgeraldAnalyst Pablo ZuanicNeutralC$9.60 -> C$11.00High
IREN
Iris Energy
2/18/2022Initiated byCantor FitzgeraldAnalyst M. ColonneseOverweight $25.00Low
VTVT
vTv Therapeutics
2/18/2022Initiated byCantor FitzgeraldAnalyst C. DuncanOverweight $5.00High
ORMP
Oramed Pharmaceuticals
2/18/2022Initiated byCantor FitzgeraldAnalyst C. DuncanOverweight $20.00Low
CYTK
Cytokinetics
2/17/2022Target Lowered byCantor FitzgeraldAnalyst Charles Duncan$57.00 -> $53.00High
PAVM
PAVmed
2/12/2022Reiterated byCantor FitzgeraldAnalyst R. OsbornOverweightHigh
COLL
Collegium Pharmaceutical
2/15/2022Upgraded byCantor FitzgeraldAnalyst B. FolkesNeutral -> Overweight$18.00 -> $26.00High
NVAX
Novavax
2/14/2022Target Lowered byCantor FitzgeraldAnalyst C. DuncanOverweight$282.00 -> $174.00High
ACB
Aurora Cannabis
2/11/2022Target Lowered byCantor FitzgeraldC$10.75 -> C$7.60High
IDEX
Ideanomics
2/11/2022Initiated byCantor FitzgeraldAnalyst A. SheppardOverweight $3.00High
LUCD
Lucid Diagnostics
2/4/2022Reiterated byCantor FitzgeraldAnalyst R. OsbornOverweightMedium
CGC
Canopy Growth
1/28/2022Target Lowered byCantor FitzgeraldAnalyst Pablo ZuanicC$16.30 -> C$9.60High
PACB
Pacific Biosciences of California
1/25/2022Reiterated byCantor FitzgeraldAnalyst R. OsbornOverweightHigh
ALKS
Alkermes
1/27/2022Upgraded byCantor FitzgeraldAnalyst B. FolkesHold -> Overweight $32.00High
CKPT
Checkpoint Therapeutics
1/26/2022Target Raised byCantor Fitzgerald$16.00 -> $20.00Medium
MAPS
WM Technology
1/25/2022Target Lowered byCantor FitzgeraldOverweight$11.00 -> $6.25High
EBS
Emergent BioSolutions
1/20/2022Target Raised byCantor Fitzgerald$50.00 -> $55.00High
XGN
Exagen
1/14/2022Reiterated byCantor FitzgeraldAnalyst R. OsbornOverweightHigh
OMER
Omeros
1/18/2022Target Lowered byCantor Fitzgerald$34.00 -> $20.00High
REE
REE Automotive
1/14/2022Initiated byCantor FitzgeraldAnalyst A. SheppardOverweight $9.00High
FOLD
Amicus Therapeutics
1/13/2022Target Lowered byCantor FitzgeraldOverweight$16.00 -> $15.00Medium
AWH
Aspira Women's Health
1/11/2022Reiterated byCantor FitzgeraldAnalyst R. OsbornOverweightHigh
OGI
OrganiGram
1/12/2022Target Lowered byCantor FitzgeraldOverweight$5.70 -> $5.30Medium
IMNM
Immunome
1/11/2022Target Lowered byCantor FitzgeraldAnalyst B. Cheng$35.00 -> $33.00High
AVPT
AvePoint
1/11/2022Initiated byCantor FitzgeraldOverweight $10.00High
BNOX
Bionomics
1/10/2022Initiated byCantor FitzgeraldAnalyst C. DuncanOverweightMedium
CTGO
Contango Ore
1/7/2022Initiated byCantor FitzgeraldOverweight $37.50Medium
PSTX
Poseida Therapeutics
1/7/2022Initiated byCantor FitzgeraldAnalyst Brian ChengOverweight $24.00High
TLRY
Tilray
1/7/2022Target Lowered byCantor FitzgeraldNeutral$11.80 -> $7.40Medium
ORTX
Orchard Therapeutics
12/30/2021Initiated byCantor FitzgeraldAnalyst P. StavropoulosOverweight$12.00 -> $9.00High
BTX
Brooklyn ImmunoTherapeutics
12/29/2021Initiated byCantor FitzgeraldOverweight $9.00N/A
NYXH
Nyxoah
12/21/2021Reiterated byCantor FitzgeraldAnalyst R. OsbornOverweightN/A
VINC
Vincerx
12/23/2021Initiated byCantor FitzgeraldAnalyst L. WatsekOverweight $25.00High
OPAD
Offerpad Solutions
12/21/2021Initiated byCantor FitzgeraldAnalyst B. SherlundOverweight $10.00High
CRDL
Cardiol Therapeutics
12/17/2021Initiated byCantor FitzgeraldAnalyst Charles DuncanBuy C$8.00N/A
CRDL
Cardiol Therapeutics
12/17/2021Initiated byCantor FitzgeraldAnalyst C. DuncanOverweight $8.00Medium
LVOX
LiveVox
12/15/2021Initiated byCantor FitzgeraldOverweight $8.00High
FAF
First American Financial
12/15/2021Target Lowered byCantor FitzgeraldOverweight$13.00 -> $10.40Medium
VLTA
Volta
12/14/2021Initiated byCantor FitzgeraldAnalyst A. SheppardOverweight $13.00High
XELA
Exela Technologies
12/10/2021Reiterated byCantor FitzgeraldBuyLow
HITI
High Tide
12/10/2021Target Lowered byCantor FitzgeraldNeutral$8.75 -> $7.75Medium
TRSSF
TerrAscend
12/8/2021Target Raised byCantor FitzgeraldOverweight -> Overweight$6.70 -> $7.65Medium
OGI
OrganiGram
12/8/2021Target Raised byCantor FitzgeraldOverweight$5.50 -> $5.70Medium
RETA
Reata Pharmaceuticals
12/7/2021Target Lowered byCantor FitzgeraldOverweight -> Overweight$230.00 -> $112.00High
ACAD
ACADIA Pharmaceuticals
12/7/2021Target Raised byCantor FitzgeraldPositive -> Overweight$27.00 -> $31.00High
CRVS
Corvus Pharmaceuticals
12/3/2021Target Raised byCantor FitzgeraldAnalyst Li WatsekOverweight -> Overweight$5.00 -> $8.00High
SLS
SELLAS Life Sciences Group
12/3/2021Target Lowered byCantor FitzgeraldAnalyst L. WatsekOverweight$18.00 -> $16.00High
AYRWF
Ayr Wellness
12/2/2021Target Lowered byCantor FitzgeraldNeutral$22.60 -> $17.50Medium
FRX
Fennec Pharmaceuticals
11/30/2021Downgraded byCantor FitzgeraldAnalyst C. DuncanOverweight -> NeutralN/A
OPTN
OptiNose
11/30/2021Reiterated byCantor FitzgeraldAnalyst B. FolkesOverweightLow
FENC
Fennec Pharmaceuticals
11/30/2021Downgraded byCantor FitzgeraldAnalyst C. DuncanOverweight -> NeutralHigh
SRRA
Sierra Oncology
11/30/2021Target Raised byCantor FitzgeraldAnalyst B. ChengOverweight$33.00 -> $39.00Low
ACHR
Archer Aviation
11/30/2021Initiated byCantor FitzgeraldAnalyst A. SheppardOverweight $14.00Medium
FAF
First American Financial
11/23/2021Initiated byCantor FitzgeraldOverweightLow
MAPS
WM Technology
11/22/2021Initiated byCantor FitzgeraldOverweight $11.00Medium
HITI
High Tide
11/22/2021Initiated byCantor FitzgeraldNeutral $8.75Low
ML
MoneyLion
11/22/2021Initiated byCantor FitzgeraldAnalyst J. SieglerOverweight $8.00High
ASND
Ascendis Pharma A/S
11/18/2021Reiterated byCantor FitzgeraldAnalyst A. YoungOverweightLow
ABEO
Abeona Therapeutics
11/18/2021Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightHigh
APS
Aptose Biosciences
11/17/2021Reiterated byCantor FitzgeraldAnalyst A. YoungOverweightN/A
APTO
Aptose Biosciences
11/17/2021Reiterated byCantor FitzgeraldAnalyst A. YoungOverweightMedium
RAPT
RAPT Therapeutics
11/16/2021Target Lowered byCantor FitzgeraldAnalyst A. YoungOverweight$71.00 -> $58.00High
ARCT
Arcturus Therapeutics
11/16/2021Target Raised byCantor FitzgeraldAnalyst B. ChengOverweight$85.00 -> $93.00Low
MNKD
MannKind
11/12/2021Reiterated byCantor FitzgeraldAnalyst B. FolkesOverweightMedium
MBIO
Mustang Bio
11/15/2021Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightLow
INVZ
Innoviz Technologies
11/11/2021Reiterated byCantor FitzgeraldAnalyst A. SheppardOverweightLow
HGEN
Humanigen
11/15/2021Reiterated byCantor FitzgeraldAnalyst L. ChenOverweightHigh
CRLBF
Cresco Labs
11/15/2021Target Raised byCantor FitzgeraldAnalyst Pablo ZuanicTop Pick -> Overweight$12.00 -> $19.00High
OTIC
Otonomy
11/11/2021Reiterated byCantor FitzgeraldAnalyst C. DuncanOverweightMedium
AZYO
Aziyo Biologics
11/11/2021Reiterated byCantor FitzgeraldAnalyst B. FolkesOverweightLow
GPL
Great Panther Mining
11/12/2021Upgraded byCantor FitzgeraldAnalyst Matthew O'KeefeBuyN/A
APTX
Aptinyx
11/10/2021Reiterated byCantor FitzgeraldAnalyst C. DuncanOverweightHigh
CWBR
CohBar
11/12/2021Initiated byCantor FitzgeraldAnalyst K. KluskaOverweight $2.50High
HYLN
Hyliion
11/11/2021Initiated byCantor FitzgeraldAnalyst J. CohenOverweight $12.00High
GTBIF
Green Thumb Industries
11/11/2021Target Raised byCantor FitzgeraldOverweight$38.00 -> $54.00High
BHVN
Biohaven Pharmaceutical
11/10/2021Target Raised byCantor FitzgeraldAnalyst Charles DuncanOverweight$165.00 -> $177.00Medium
REGN
Regeneron Pharmaceuticals
11/10/2021Target Raised byCantor FitzgeraldAnalyst Alethia YoungPositive -> Overweight$700.00 -> $760.00Medium
STOK
Stoke Therapeutics
11/9/2021Reiterated byCantor FitzgeraldAnalyst A. YoungOverweightHigh
AXSM
Axsome Therapeutics
11/9/2021Reiterated byCantor FitzgeraldAnalyst C. DuncanOverweightHigh
CMPS
COMPASS Pathways
11/9/2021Target Raised byCantor FitzgeraldPositive -> Overweight$71.00 -> $82.00High
VFF
Village Farms International
11/9/2021Upgraded byCantor FitzgeraldNeutral -> Overweight$11.50 -> $12.75High
MDRX
Allscripts Healthcare Solutions
11/5/2021Reiterated byCantor FitzgeraldAnalyst S. HalperNeutralMedium
ADMA
ADMA Biologics
11/8/2021Initiated byCantor FitzgeraldAnalyst K. KluskaOverweight $4.50Medium
LUCD
Lucid Diagnostics
11/8/2021Initiated byCantor FitzgeraldAnalyst C. DuncanOverweight $21.00High
PFE
Pfizer
11/5/2021Reiterated byCantor FitzgeraldAnalyst Louise ChenBuy $60.00Low
SRPT
Sarepta Therapeutics
11/4/2021Target Raised byCantor FitzgeraldOverweight$128.00 -> $140.00High
DRRX
DURECT
11/3/2021Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightLow
AYRWF
Ayr Wellness
11/3/2021Target Lowered byCantor FitzgeraldNeutral$33.50 -> $22.60High
CRLBF
Cresco Labs
11/3/2021Target Lowered byCantor FitzgeraldAnalyst Pablo ZuanicOverweight$12.65 -> $12.00Low
GTBIF
Green Thumb Industries
11/3/2021Target Lowered byCantor FitzgeraldAnalyst Pablo ZuanicOverweight$46.00 -> $38.00Low
TRSSF
TerrAscend
11/3/2021Target Lowered byCantor FitzgeraldOverweight$8.65 -> $6.70Low
CLNN
Clene
11/3/2021Target Lowered byCantor FitzgeraldAnalyst C. DuncanOverweight$24.00 -> $15.00Medium
NBIX
Neurocrine Biosciences
11/2/2021Target Raised byCantor FitzgeraldOverweight$117.00 -> $123.00High
VXRT
Vaxart
11/2/2021Initiated byCantor FitzgeraldAnalyst C. DuncanOverweight $15.00High
OCGN
Ocugen
11/2/2021Reiterated byCantor FitzgeraldAnalyst K. KluskaNeutral $4.00High
THRX
Theseus Pharmaceuticals
11/1/2021Initiated byCantor FitzgeraldAnalyst A. YoungOverweight $25.00Medium
TLRY
Tilray
11/1/2021Downgraded byCantor FitzgeraldOverweight -> Neutral$18.00 -> $11.80High
ALNY
Alnylam Pharmaceuticals
10/29/2021Target Raised byCantor FitzgeraldOverweight$202.00 -> $275.00Low
IMNM
Immunome
10/29/2021Initiated byCantor FitzgeraldAnalyst B. ChengOverweight $35.00Low
TDOC
Teladoc Health
10/28/2021Target Lowered byCantor FitzgeraldNeutral$185.00 -> $150.00High
BIIB
Biogen
10/28/2021Target Lowered byCantor FitzgeraldAnalyst Alethia YoungNeutral$316.00 -> $259.00Medium
QURE
uniQure
10/26/2021Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightMedium
ETNB
89bio
10/26/2021Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweight$58.00 -> $49.00High
OPA
Magnum Opus Acquisition
10/21/2021Initiated byCantor FitzgeraldOverweight $10.00Low
PRQR
ProQR Therapeutics
10/18/2021Reiterated byCantor FitzgeraldAnalyst B. ChengOverweightLow
ORTX
Orchard Therapeutics
10/18/2021Reiterated byCantor FitzgeraldAnalyst P. StavropoulosOverweightMedium
KDNY
Chinook Therapeutics
10/18/2021Reiterated byCantor FitzgeraldAnalyst C. DuncanOverweightMedium
HARP
Harpoon Therapeutics
10/18/2021Reiterated byCantor FitzgeraldAnalyst B. ChengOverweightLow
GOSS
Gossamer Bio
10/18/2021Reiterated byCantor FitzgeraldAnalyst B. ChengOverweightLow
FMTX
Forma Therapeutics
10/18/2021Reiterated byCantor FitzgeraldAnalyst A. YoungOverweightHigh
ETNB
89bio
10/18/2021Reiterated byCantor FitzgeraldAnalyst K. KluskaOverweightLow

MarketBeat Community Rating for Cantor Fitzgerald

Community Ranking:  2.8 out of 5 (
2.8 of 5 stars)
Outperform Votes:  17,754 (Vote Outperform)
Underperform Votes:  14,141 (Vote Underperform)
Total Votes:  31,895
MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.
See Also:

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.